<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(11)</volume><submitter>Sykes DB</submitter><funding>European Hematology Association</funding><funding>NCI NIH HHS</funding><journal>Expert opinion on therapeutic targets</journal><pagination>893-898</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6457988</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia.</pubmed_title><pmcid>PMC6457988</pmcid><funding_grant_id>TRTH86</funding_grant_id><funding_grant_id>K08 CA201640</funding_grant_id><pubmed_authors>Sykes DB</pubmed_authors></additional><is_claimable>false</is_claimable><name>The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Nov</publication><modification>2025-04-26T18:17:19.422Z</modification><creation>2025-04-06T15:45:55.511Z</creation></dates><accession>S-EPMC6457988</accession><cross_references><pubmed>30318938</pubmed><doi>10.1080/14728222.2018.1536748</doi></cross_references></HashMap>